Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...

Full description

Bibliographic Details
Main Authors: Adriana Bezerra-Souza, Raquel Fernandez-Garcia, Gabriela F. Rodrigues, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Passero, Aikaterini Lalatsa, Dolores R. Serrano
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Pharmaceutics
Subjects:
butenafine
SNEDDS
solid SNEDDS
spray drying
leishmaniasis
design of experiments
Online Access:https://www.mdpi.com/1999-4923/11/7/353

Internet

https://www.mdpi.com/1999-4923/11/7/353

Similar Items